Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).

Medically reviewed by Beth Thomas, PharmD Fact checked by Nick Blackmer N-acetylcysteine (NAC) supplements are proposed to ...

NAC reduced CRP and IL-8 in a dose-dependent manner, which was associated with a beneficial effect on clinical and functional outcomes. The data presented here do not allow us to ascertain whether ...

Nebulization-face mask, mouth piece, tracheostomy: 1–10mL of 20% soln or 2–20mL of 10% soln every 2–6 hours; usual dose: 3–5mL of 20% soln or 6–10mL of 10% soln 3–4 times daily.